Follow us on
Welcome Guest! You are here: Home » Health
This drug may stimulate immune system in patients affected by blood cancer

Thursday March 9, 2017 12:41 PM, ANI

Blood Cancer Drugs

A team of US researchers have found an experimental drug that may stimulate the immune system - leading to tumor shrinkage - in patients affected by blood cancer.

The research appeared in journal Nature Medicine.

Multiple Myeloma is a blood cancer that affects plasma cells - white blood cells that normally produce antibodies to fight infection.

Of the study of 25 Multiple Myeloma patients, the research highlights the importance of studying the effects of drug - LCL161 - not only on the tumor cells in a culture plate, but also on the interaction of the tumor cells with their own microenvironment.

"The drug, LCL161, was initially developed to promote tumor death," said lead study author Marta Chesi from Mayo Clinic in the US.

"However, we found that the drug does not kill tumor cells directly. Rather, it makes them more visible to the immune system that recognises them as foreigner invaders and eliminates them," Chesi added.

The finding suggest that LCL161 is active against multiple myeloma suggests that similar drugs may have broader clinical activity than previously thought.

As the cancer cells grow, they secrete large amounts of a single antibody that accumulate in the body, causing kidney problems and infections.

"The model for preclinical studies to predict with great accuracy which drugs would work in the clinic was developed a decade ago," says Dr. Chesi. "And it has been instrumental in the prioritisation of which experimental therapeutics should be tested in patients with multiple myeloma."

The researchers will conduct a follow-up clinical trial of LCL161 in combination with an inhibitor of immune checkpoints that has been widely used in many cancer treatments.



Share this page
More Headlines
Inflammation in regeneration is beneficial or risk - Scientists research
Lacking in Job Satisfaction? Maintain your sex life and see the results
Latest research reveals early periods link with risk of gestational diabetes
Maharashtra Class 12 HSC paper leaked on social media; Four arrested
AIMIM Telangana MLA Kausar Mohiuddin booked for 'assaulting' woman
Upset over Mumbai BMC poll debacle, Owaisi to induce fresh blood into AIMIM Maharashtra unit
Conspiracy charges against Advani, other BJP, VHP leaders in Babri Masjid case may be revived
How safe are online pharmacies?
Madrassas and Sarswati Shishu Mandirs can't be tarred with the same brush
Watchdog approves two drugs for treatment of bowel cancer
Organ-on-a-chip model offers clues to Hutchinson-Gilford Progeria Syndrome
Netanyahu suggests law to prevent streets being named after Nobel peace winner Yasser Arafat
EKOS Research poll shows four in five Canadians back Israeli boycott
After Ramzan and Qabristan jibes, Prime Minister Modi urges 'Muslim Brothers' to join hands
Syed Shahabuddin - Top bureacurate who refused ministerial berths to speak for Muslims
Now, Sikh man shot at in US; Masked white attacker yelled 'go back to your own country'
RRB NTPC Stage II Exam: Results in process, boards need more time to finalise
After techie, Indian-origin businessman shot dead in US
Protest over "out of syllabus" Class 12 paper leaves girl, cop injured
BJP to support Shiv Sena nominees in Mumbai Mayor, Dy Mayor elections: Fadnavis
Vishvanath Mahadeshwar, Hareshwar Worlikar Sena nominees for Mayor, Dy Mayor posts in Mumbai

 Post Comments
Note: By posting your comments here you agree to the terms and conditions of